Bayer submits its new hemophilia drug for EU scrutiny; More turmoil for Sanofi;

@FierceBiotech: Does the 'sharing economy' have a place in biotech? More | Follow @FierceBiotech

@JohnCFierce: $GSK news blew away the rest of the yr's top 10 reports in terms of readers. And it was all industry/investors. Story | Follow @JohnCFierce

@DamianFierce: Sorting through $PFE for $BMY tweets is like a survey course in the epidemiology of bio Twitter BS. Highly recommended. | Follow @DamianFierce

> As promised, Bayer has filed a European application for BAY 81-8973, a new hemophilia A treatment designed to improve upon the company's own Kogenate. Bayer plans to submit filings in other countries in the coming months. News

> Sanofi ($SNY) revealed that the head of its diabetes business resigned just weeks before the company unveiled flat sales projections for the business, inviting more scrutiny on a drugmaker working to move on from a high-profile CEO firing and fight new allegations of paying kickbacks to physicians. More

Medical Device News

@FierceMedDev: Welch Allyn partners with LKC to distribute novel diabetic retinopathy device. Story | Follow @FierceMedDev

@EmilyWFierce: Covidien loses battle in patent war with J&J as top U.S. patent court throws out $176M award. More | Follow @EmilyWFierce

> Welch Allyn partners with LKC to distribute novel diabetic retinopathy device. News

> Covidien loses battle in patent war with J&J as top U.S. patent court throws out $176M award. More

> Congress looks to deflate Medicare coverage of penis pumps. Story

Pharma News

@FiercePharma: Sanofi Chairman says French tax burden a killer for attracting execs. Story | Follow @FiercePharma

@EricPFierce: ICYMI: Sanofi, Viehbacher accused of kickback scheme in whistleblower suit. Article | Follow @EricPFierce

@CarlyHFierce: Reckitt CEO, nearing spinoff, thinks he can outdo Big Pharma in consumer health. Story | Follow @CarlyHFierce

> GSK changes its tune, plans to hold on to aging drug portfolio. More

> More turmoil in top ranks of Sanofi's diabetes business. News

> Reckitt CEO, nearing spinoff, thinks he can outdo Big Pharma in consumer health. Story

Suggested Articles

Panelists at the CAR-TCR Summit reflected on gender diversity trends and the challenges women face in the life sciences industry.

Loh joins the computational chemistry specialist after a two-year stint at Kymera Therapeutics.

The $3 billion funding boost includes an additional $350 million for targeted Alzheimer’s research.